BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 1592842)

  • 1. Tricyclic antidepressant-induced seizures and plasma drug concentration.
    Preskorn SH; Fast GA
    J Clin Psychiatry; 1992 May; 53(5):160-2. PubMed ID: 1592842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tricyclic antidepressant concentrations in plasma: an estimate of their sensitivity and specificity as a predictor of response.
    Perry PJ; Zeilmann C; Arndt S
    J Clin Psychopharmacol; 1994 Aug; 14(4):230-40. PubMed ID: 7962678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma concentrations of tricyclic antidepressants in clinical practice.
    Hollister LE
    J Clin Psychiatry; 1982 Feb; 43(2):66-9. PubMed ID: 7056706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tricyclic antidepressants: the whys and hows of therapeutic drug monitoring.
    Preskorn SH
    J Clin Psychiatry; 1989 Jul; 50 Suppl():34-42; discussion 43-6. PubMed ID: 2661550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Managing rapid metabolizers of antidepressants.
    Kraus RP; Diaz P; McEachran A
    Depress Anxiety; 1996-1997; 4(6):320-7. PubMed ID: 9166660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low serum levels of tricyclic antidepressants in amitriptyline- and doxepin-treated inpatients with depressive syndromes are associated with nonresponse.
    Rao ML; Deister A; Laux G; Staberock U; Höflich G; Möller HJ
    Pharmacopsychiatry; 1996 May; 29(3):97-102. PubMed ID: 8738313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The value of assays in tricyclic antidepressant therapy.
    Clower CG
    Indiana Med; 1991 Aug; 84(8):550-2. PubMed ID: 1680895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic drug monitoring of tricyclic antidepressants: how does it work under clinical conditions?
    Müller MJ; Dragicevic A; Fric M; Gaertner I; Grasmäder K; Härtter S; Hermann E; Kuss HJ; Laux G; Oehl W; Rao ML; Rollmann N; Weigmann H; Weber-Labonte M; Hiemke C
    Pharmacopsychiatry; 2003 May; 36(3):98-104. PubMed ID: 12806567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic drug monitoring for antidepressants: efficacy, safety, and cost effectiveness.
    Preskorn SH; Fast GA
    J Clin Psychiatry; 1991 Jun; 52 Suppl():23-33. PubMed ID: 1904862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapeutic drug monitoring in depression--new perspectives].
    Radziwoń-Zaleska M; Matsumoto H; Skalski M; Dziklińska A; Androsiuk W; Wakarow A; Wilkowska J; Matoszko D; Kuczyńska J; Goluch J
    Psychiatr Pol; 2002; 36(6 Suppl):71-80. PubMed ID: 12647424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seizures associated with antidepressants: a review.
    Rosenstein DL; Nelson JC; Jacobs SC
    J Clin Psychiatry; 1993 Aug; 54(8):289-99. PubMed ID: 8253696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Fluoxetine and tricyclic antidepressants: clinical tolerance in short-term combined administration].
    Bonin B; Bertschy G; Baumann P; Francois T; Vandel P; Vandel S; Sechter D; Bizouard P
    Encephale; 1996; 22(3):221-7. PubMed ID: 8767051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Tricyclic antidepressants dosage and depressed elderly inpatients: a retrospective pharmaco-epidemiologic study].
    Ballon N; Siobud-Dorocant E; Even C; Slama F; Dardennes R
    Encephale; 2001; 27(4):373-6. PubMed ID: 11686060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma level monitoring of antidepressants: theoretical basis and clinical application.
    Gram LF; Kragh-Sørensen P; Kristensen CB; Møller M; Pedersen OL; Thayssen P
    Adv Biochem Psychopharmacol; 1984; 39():399-411. PubMed ID: 6380231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioral and cognitive toxicity related to elevated plasma tricyclic antidepressant levels.
    Meador-Woodruff JH; Akil M; Wisner-Carlson R; Grunhaus L
    J Clin Psychopharmacol; 1988 Feb; 8(1):28-32. PubMed ID: 3350996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical pharmacokinetics of tricyclic antidepressants Part II. Drug therapy monitoring].
    Szymura-Oleksiak J; Wasieczko A; Wyska E; Zieba A
    Psychiatr Pol; 1994; 28(1):17-26. PubMed ID: 8190816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of seizures during treatment with tricyclic antidepressant drugs and bupropion.
    Peck AW; Stern WC; Watkinson C
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):197-201. PubMed ID: 6406457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The jitteriness syndrome in panic disorder patients treated with antidepressants.
    Pohl R; Yeragani VK; Balon R; Lycaki H
    J Clin Psychiatry; 1988 Mar; 49(3):100-4. PubMed ID: 3346196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The safety of switching rapidly from tricyclic antidepressants to monoamine oxidase inhibitors.
    Kahn D; Silver JM; Opler LA
    J Clin Psychopharmacol; 1989 Jun; 9(3):198-202. PubMed ID: 2738181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tricyclic antidepressant poisoning: an evidence-based consensus guideline for out-of-hospital management.
    Woolf AD; Erdman AR; Nelson LS; Caravati EM; Cobaugh DJ; Booze LL; Wax PM; Manoguerra AS; Scharman EJ; Olson KR; Chyka PA; Christianson G; Troutman WG
    Clin Toxicol (Phila); 2007; 45(3):203-33. PubMed ID: 17453872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.